84 results
425
CELG
Celgene Corporation
25 Mar 19
Business combination disclosure
5:25pm
for sustainable long-term growth. We disagree with those shareholders that have expressed concerns with some aspects of the transaction. Your Board has … , earnings and margins over the last five years. Our acute focus on sustainable growth has resulted in Bristol-Myers Squibb generating 60% of 2018 sales
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
approvals. Writing the Next Chapter for New and Sustainable Growth Trajectory as We Deliver Transformative Medicines for Patients 16 new products … fortune 100 companies that have invested $1 billion with diverse-owned suppliers 3
4 Delivering Sustainable Growth and Innovation $45.0B Total
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
8 Jan 24
Regulation FD Disclosure
10:29am
results.
We are writing the next chapter in our history 3 Our overarching goal is to achieve sustainable, top-tier growth by the end of the decade BMS … Industry Headwinds
Our overarching goal is to achieve sustainable, top-tier growth Transition period Maximize performance through 2025 Sustainable
8-K
EX-99.3
BMY
Bristol-Myers Squibb Co.
3 Jan 19
Regulation FD Disclosure
7:58am
sustainable growth and deliver new options for patients across a range of serious diseases,” said Giovanni Caforio, M.D., Chairman and Chief Executive … -Oncology (IO).
Early-stage pipeline builds sustainable platform for growth. The combined company will have a deep and diverse early-stage pipeline across
425
EX-99.3
kd3h5ueml4x7z42k r3r
3 Jan 19
Business combination disclosure
7:56am
DEFA14A
aja4qnn45 11uala
20 Apr 22
Additional proxy soliciting materials
4:30pm
425
99lt72c
8 Mar 19
Business combination disclosure
5:20pm
425
du7n37
28 Feb 19
Business combination disclosure
6:08am
425
oi8hn0g9v
3 Jan 19
Business combination disclosure
5:18pm
425
0u62yw28y
29 Mar 19
Business combination disclosure
4:30pm
DEFA14A
tyimx10djbnt xr15n
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.1
w710w 50wx3gh
25 Apr 13
Bristol-Myers Squibb Reports First Quarter 2013 Financial Results
12:00am
425
2k9oavuenhbzx5ba
19 Mar 19
Business combination disclosure
7:02am
8-K
EX-99.2
sxvomj7a
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
8-K
EX-99.3
sn8zbit4gryfd
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am
8-K
EX-99.3
qozjdyghcz2 lts1iln7
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am